scholarly journals Automatic detection of Crohn's disease using quantified motility in magnetic resonance enterography: initial experiences

Author(s):  
A. Arkko ◽  
T. Kaseva ◽  
E. Salli ◽  
T. Mäkelä ◽  
S. Savolainen ◽  
...  
2012 ◽  
Vol 142 (5) ◽  
pp. S-169
Author(s):  
Danny Cheriyan ◽  
Eoin Slattery ◽  
Shaunagh McDermott ◽  
Aoife Kilcoyne ◽  
Denise Keegan ◽  
...  

2017 ◽  
Vol 152 (5) ◽  
pp. S768-S769
Author(s):  
Alexandre Coimbra ◽  
Jordi Rimola ◽  
Miriam Cuatrecasas ◽  
Gert De Hertogh ◽  
Gert A. Van Assche ◽  
...  

2016 ◽  
Vol 8 (2) ◽  
pp. 93-101 ◽  
Author(s):  
Arvin Aryan ◽  
Zahra Azizi ◽  
Azam Teimouri ◽  
Nasser Ebrahimi Daryani ◽  
Najme Aletaha ◽  
...  

2018 ◽  
Vol 16 (1) ◽  
pp. 75-82.e5 ◽  
Author(s):  
Aida Kapic Lunder ◽  
Jørgen Jahnsen ◽  
Linda Tøften Bakstad ◽  
Arne Borthne ◽  
Johannes Roksund Hov ◽  
...  

2018 ◽  
Vol 11 ◽  
pp. 175628481876595 ◽  
Author(s):  
Noa Rozendorn ◽  
Marianne Michal Amitai ◽  
Rami Abraham Eliakim ◽  
Uri Kopylov ◽  
Eyal Klang

Magnetic resonance enterography (MRE) is a leading radiological modality in Crohn’s disease (CD) and is used together with laboratory findings and endoscopic examinations for the evaluation of patients during initial diagnosis and follow up. Over the years, there has been great progress in the understanding of CD and there is a continuous strive to achieve better monitoring of patients and to develop new modalities which will predict disease course and thus help in clinical decisions making. An objective evaluation of CD using a quantification score is not a new concept and there are different clinical, endoscopies, radiological and combined indices which are used in clinical practice. Such scores are a necessity in clinical trials on CD for evaluation of disease response, however, there is no consensus of the preferred MRE score and they are not routinely used. This review presents MRE-based indices in use in the last decade: the Magnetic Resonance Index of Activity (MaRIA), the Clermont score, the Crohn’s Disease Magnetic Resonance Imaging (MRI) Index (CDMI), the Magnetic Resonance Enterography Global Score (MEGS) and the Lemann index. We compare the different indices and evaluate the clinical research that utilized them. The aim of this review is to provide a reference guide for researchers and clinicians who incorporate MRE indices in their work. When devising future indices, accumulated data of the existing indices must be taken into account, as each of the current indices has its own strengths and weakness.


2020 ◽  
Vol 7 (1) ◽  
pp. e000365 ◽  
Author(s):  
David Henry Bruining ◽  
Salvatore Oliva ◽  
Mark R Fleisher ◽  
Monika Fischer ◽  
Joel G Fletcher

IntroductionCrohn’s disease diagnosis and monitoring remains a great clinical challenge and often requires multiple testing modalities. Assessing Crohn’s disease activity in the entire gastrointestinal (GI) tract using a panenteric capsule endoscopy (CE) system could be used as an alternative to colonoscopy and cross-sectional imaging. This study assessed the accuracy and safety of panenteric CE in Crohn’s disease as compared with ileocolonoscopy (IC) and/or magnetic resonance enterography (MRE).MethodsA prospective, multicentre study was performed in subjects with established Crohn’s disease. Individuals with proven small bowel patency underwent a standardised bowel preparation, followed by CE ingestion and IC either the same or following day. MRE, IC, and CE interpretations were performed by blinded central readers using validated scoring systems. The primary endpoint was the overall sensitivity of CE vs MRE and/or IC in Crohn’s disease subjects.ResultsStudy enrolment included 158 subjects from 21 sites in the USA, Austria, and Israel. Of those, 99 were included in the analysis. Imaging modality scores indicated none to mild inflammation in the proximal small bowel and colon, but discrepant levels of inflammation in the terminal ileum. Overall sensitivity for active enteric inflammation (CE vs MRE and/or IC) was 94% vs 100% (p=0.125) and specificity was 74% vs 22% (p=0.001). Sensitivity of CE was superior to MRE for enteric inflammation in the proximal small bowel (97% vs 71%, p=0.021), and similar to MRE and/or IC in the terminal ileum and colon (p=0.500–0.625). There were seven serious adverse advents of which three were related to the CE device.ConclusionPanenteric CE is a reliable tool for assessing Crohn’s disease mucosal activity and extent compared with more invasive methods. This study demonstrates high performance of the panenteric CE as compared to MRE and/or IC without the need for multiple tests in non-stricturing Crohn’s disease.Trial registration numberClinicalTrials.gov NCT03241368


Sign in / Sign up

Export Citation Format

Share Document